ACADEMIC:

• B.Pharm. Jadavpur University, Kolkata, West Bengal India- 2008
• M.Pharm. (Pharmacology)-Jadavpur University, Kolkata, West Bengal India -2010
• Ph.D. (Pharmacy). Jadavpur University, Kolkata, West Bengal India -2014
• Post Doc. University of the Free State, Bloemfontein, WHO-NRF Bilateral Project -2017

EMPLOYMENT

• Associate Professor-I; Division of Life Sciences, Institute of Advanced Study in Science and Technology (IASST), Vigyan Path, Guwahati, PIN- 781035 Assam, India (Oct 2022 onwards)
• Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research- Hajipur (Dept. of Pharmaceutical, Govt. of India) Bihar, India.
• Post-Doctoral Research Fellow; Department of Pharmacology, University of the Free State, Bloemfontein, South Africa
• Division of Pharmacology, Guru Nanak Institute of Pharmaceutical Science and Technology, (An Autonomous Institute by UGC) Kolkata, India. (Availed Sabbatical leave for Post-Doctoral Research)

AWARDS/ RECOGNITION/ACHIEVEMENT: 

• Nov 2024: Dr. Asis Bala was awarded the "Best Publication Award 2024" by the Society for Ethnopharmacology (SFE) India. This honor was bestowed upon him during the 11th Society and International Conference Convention held in Gangtok, Sikkim, on November 15-16, 2024.
• March 2024 : Awarded - "Edward Moore Kennedy Memorial Award” for the presentation as an invited speaker and based on the research credentials on Cancer at the 8th World Cancer Congress 2024 at the JNU Convention Centre in New Delhi.
• August 2023: Nominated and Selected as Associate Editor- European Journal of Medical Research (Section Oncology) Impact factor 4.2- Springer Nature- BMC
• March 2023: Received Bentham Outstanding Reviewer Award 2023.
• June 2022: Received “JIS SAMMAN” as Faculty with “Highest number of Publications”; Awarded by JIS Group Kolkata.
• February 2021: Received “JIS SAMMAN” as Faculty with “Best Research Credential”; Awarded by JIS Group Kolkata.
• June 2021: Doctoral Committee Member at Maulana Abul Kalam Azad University of Technology (MAKAUT), West Bengal Dept. of Biomedical Engineering.
• May 2020: Selected as Associate Editorial Board Member, Endocrine Metabolic & Autoimmune Disorders, (JCR 2021 Impact Factor 387), Published by Bentham Science Publication- Official Journal of Association of Medical Endocrinologists- Italy.
• Jan 2019- Nov 2019: Served as Academic Coordinator (Pharmacology and Toxicology); National Institute of Pharmaceutical Education and Research (NIPER), (Department of Pharmaceutical Govt. of India).
• June 2018: Received “Outstanding Contribution for Reviewer Award” from Elsevier, Journal of Ethnopharmacology (Impact Factor: 5.195).
• 2018- onwards: Selected and qualified as CPCSEA (Ministry of Fisheries, Animal Husbandry and Dairying, Govt. of India) nominee of the Institutional Animal Ethical Committee
• Jan 2018: Received the University of the Free State- Travel Grant to attend ISE- SFEC 2018, At the University of Dhaka, Dhaka Bangladesh, and January 13-15
• October 2017: Received Travel Grant to Attend India-South Africa Collaborative Meet 2017, Hotel Southern , Durban, South Africa.
• August 2017: Received “Outstanding Contribution for Reviewer Award” from Elsevier, International Journal of Biological Macromolecules (Impact Factor: 8.025).
• September 2017: Received Bursaries to attend DST-RSA Science IKS Exhibition Nelspruit, Mpumalanga South Africa, September 26-29.
• 2017 onwards: Member of the South African Society of Basic and Clinical Pharmacology.
• 2016 onwards: Life Member of the Indian Pharmacy Graduate Association.
• 2016: Organized International Seminar at Guru Nanak Institute of Pharmaceutical Science and Technology as Organizing Secretary in collaboration with the Indian Pharmacy Graduate Association.
• 2015: Organized West Bengal State Council of Science & Technology sponsored and DST Govt. of India supported one-day “National Seminar- National Science Day” at Guru Nanak Institute of Science and Technology as Organizing Secretary.
• December 2015: Received “Dr. A.K. Nag Chaudhury Memorial Award” From Society for Ethnopharmacology -India, in 2nd National convention organized by SNPS Jadavpur University Kolkata.
• 2014-2015: Experienced as “Officer in Charge” of the University Semester Examination of West Bengal University of Technology presently MAKAUT at GNIPST.
• 2015 - onwards: Selected as Editorial Board Member of the Journal” Advanced in Modern Oncology Research” by “PiscoMed Publishing”
• Dec 2012: Received Travel Grant” and Bursaries to attend the ISE 2012, Organized by the International Society of Ethnopharmacology, at Science City Kolkata, India
• 2011- Senior Research Fellowship (SRF) Awarded Indian Council of Medical Research (ICMR).
• 2010- Junior Research Fellowship (JRF) at Department of Pharmacology, Institute of Post Graduate Medical Education and Research (IPGME&R), Kolkata (BRNS-DAE Funded Project).
• 2008: Qualified GATE (Pharmaceutical Science)

HIGHLIGHTS: -  https://www.eurekaselect.com/ebook_volume/3707

PUBLICATIONS:

https://orcid.org/0000-0002-2148-2331

https://www.scopus.com/authid/detail.uri?authorId=35772222300

2026 (IASST).

1. Kesarwani R, Pal N, Das D, Bala A*, Bhabak KP*. Rational Development of Activatable Prodrugs of the GSTP1 Inhibitor NBDHEX: Turn-On NIR Fluorogenic Drug Delivery with Selective Anticancer Activity. J Med Chem. 2026 Jul 2. doi: 10.1021/acs.jmedchem.6c01286. (Impact Factor: 7.3). (Corresponding author).
2. Bhattacharjee MJ, Sheikh Y, Das S, Bala A, Mukherjee AK, Khan MR. The antidiabetic potential of Leuconostoc mesenteroides strain SB1075 fermented soy yoghurt: Insights from mouse intestinal transcriptomics and metabolite analyses. Food Res Int. 2026 Jul 31;236:119241. doi: 10.1016/j.foodres.2026.119241. (Impact Factor: 8.8). (Co-Author).
3. Bhattacharya H, Chakraborty P, Kandar S, Bala A*, Dewanjee S*. Nanoparticle-based strategies as emerging tools for oral chemotherapy of colorectal cancer. 3 Biotech. 2026 Jun;16(6):216. doi: 10.1007/s13205-026-04846-4. (Impact Factor: 3.1). (Joint Corresponding author).
4. Talukdar, Punam, Gohain, Reetesh Borpatra, Biswas, Subir, Bala, Asis. Cold Atmospheric Plasma in Biomedicine and Pharmacology: Multidisciplinary Perspectives on Therapeutic Applications. American Chemical Society- ACS Pharmacology & Translational Science2026/03/15.doi: 10.1021/acsptsci.6c00042. (Impact Factor: 4). (Corresponding author).
5. Saha S, Mondal S, Chatterjee O, Devroy P, Sur D, Bala A. Bromocriptine Attenuated Ulcerative Colitis and Colonic Inflammation by Inhibiting IL-1β, Likely through NF-κB Down-regulation: Integrated Network Pharmacology and in vivo Experimental Validation. Curr Pharm Des. 2026 Apr 10. doi: 10.2174/0113816128418229260223013818. (Impact Factor: 3.2). (Corresponding author).
6. Shaharyar MA, Bhowmik R, Sarkar A, De A, Mandal A, Tiwari V, Chakraborty S, Banerjee SK, Akhtar J, Ayyoob M, Roshan S, Bala A*, Karmakar S*. Khamira Gaozaban Sada, a Low-Cost Unani Preparation, Alleviates Isoproterenol and L-NAME-Induced Augmented Cardiac Workload. Curr Pharm Des. 2026 Feb 20. doi: 10.2174/0113816128433225260113065940.(Impact Factor: 3.2). (Joint Corresponding author).
7. Rosy Mahato, Dev Madhubala, Asis Bala, Mojibur R. Khan, Ashis K. Mukherjee,A commercial insecticide-induced neurotoxicity and snake venom nerve growth factor-inspired peptides-mediated neuroprotection in Caenorhabditis elegans: Mechanistic, safety, and pharmacokinetic (in vivo imaging) evaluation of peptides,Toxicon,2026,109038. https://doi.org/10.1016/j.toxicon.2026.109038. (Impact Factor: 2.8). (Co Author).
8. Boro B, Barman M, Sonkar R, Talukdar P, Bala A, Chowdhury D. Biocompatible protein-nanomaterial scaffolds for controlled drug delivery. RSC Adv. 2026 Jan 23;16(6):5179-5193. doi: 10.1039/d5ra09090c.(Impact Factor: 6.1). (Co-author).
9. Bitopan Boro, Bitupan Mohan, Mridusmita Barman, Punam Talukdar, Asis Bala, Devasish Chowdhury, Chitosan–Collagen/h-BN nanocomposites: A sustainable approach to thermoelectric material design, Materials Science and Engineering: B, 327,2026,119255, https://doi.org/10.1016/j.mseb.2026.119255. (Impact Factor: 5.7). (Co-author).

2025 (IASST)

1. Barman P, Chakraborty R, Misra R, Bhuyan HJ, Roy S, Sarkar S, Bala A*, P Bhabak K*. Nitro-Substituted Benzylic Organochalcogenides as Anticancer Agents: Unravelling the Multifaceted Pathways to Combat Triple-Negative Breast Cancer. J Med Chem. 2025 Aug 3. doi: 10.1021/acs.jmedchem.5c01314. (Impact Factor: 7.3). (Joint Corresponding author).
2. Maloyjo Joyraj Bhattacharjee, Asis Bala, Mojibur R. Khan, Ashis K. Mukherjee,Functional impact of bioactive peptides derived from fermented foods on diverse human populations, Food Chemistry, 2025,145416,https://doi.org/10.1016/j.foodchem.2025.145416. (Impact Factor: 10.4). (Co-author).
3. Bala, Asis. "Biochemical Ferrous Ions (Fe 2+) Mediated Fenton Reaction: A Biological Prodigy for Curing and Developing Autoimmune Rheumatoid Arthritis and Cancer." Journal of Environmental Pathology, Toxicology and Oncology 44.3 (2025). DOI: 10.1615/JEnvironPatholToxicolOncol.2024053436 (Impact Factor: 2.9). (Sole author).
4. Devroy P, Das D, *Bala A, *Mukherjee AK. A comprehensive review of scientifically reported phytochemicals to manage allodynia in chronic diabetes complications. J Pharm Pharmacol. 2025 (In Press): rgaf012. doi: 10.1093/jpp/rgaf012. (Impact Factor: 3.2). (Joint Corresponding author).
5. Chakraborty R., Gohain R.B., Talukdar P., Changkakoti L.,  Biswas S.,   Mukherjee A.K. and Bala A.,  Pre-clinical Safety Study of Cold Atmospheric Plasma (CAP) Produced by an Inbuilt CAP Device and ROS Mediated Apoptotic Activity in Human Skin Melanoma Cells. Current Pharm. Design. 2025 (In Press): DOI: 10.2174/0113816128335012250122221541: (Impact Factor: 2.8). (Corresponding author).
6. Changkakoti L, Rajabalaya R, David SR, Balaraman AK, Sivasubramanian H, Mukherjee AK, Bala A. Exploration of the Role of Vitamins in Preventing Neurodegenerative Diseases: Comprehensive Review on Preclinical and Clinical Findings. Curr Neuropharmacol. 2025;23(5):547-563. doi: 10.2174/011570159X327677240902105443. (Impact Factor: 5.3). (Corresponding author).
7. Roy, Susmita; Parveen, Mehnaz; Bala, Asis *; Sur, Debjeet*. The 3C (Cell Culture, Computer Simulation, Clinical Trial) Solution for Optimizing the 3R (Replace, Reduction, Refine) Framework during Preclinical Research Involving Laboratory Animals. ACS Pharmacology & Translational Science. 2025. https://doi.org/10.1021/acsptsci.4c00661. (Impact Factor: 5.1). (Joint Corresponding author).
8. Kumar R, Haripriya V, Patra A, Kalita B, Vanuopadath M, Nair BG, Mahato R, Lalremsanga HT, Khan MR, Bala A, Mukherjee AK. Proteomic and functional characterisation of Trimeresurus popeiorum (Pope's pit viper) venom proteins: Role of enzymatic and non-enzymatic venom toxins in envenomation pathophysiology. Int J Biol Macromol. 2025 Feb 4:140638. doi: 10.1016/j.ijbiomac.2025.140638. (Impact Factor: 7.7). (Co-author).
9. Sultana N, Andagonde SV, Chakraborty R, Bala A, Sen Sarma N. A non-enzymatic dual sensing approach for the detection of cholesterol in real samples using silk fiber functionalized phosphorene quantum dots. Nanoscale. 2025 Feb 6;17(6):3042-3052. doi: 10.1039/d4nr03945a. (Impact Factor: 5.8). (Co-author).

2024 (IASST)

1. Chakraborty R, Mukherjee AK, Bala A. Interleukin-35: A key player managing pre-diabetes and chronic inflammatory type 1 autoimmune diabetes. World J Diabetes. 2024 Oct 15;15(10):2147-2151. doi: 10.4239/wjd.v15.i10.2147. (Impact Factor: 4.2). (Corresponding author).
2. Chakraborty R, Mukherjee AK, Bala A. Breakthroughs in road mapping IL-35 mediated immunotherapy for type-1 and autoimmune diabetes mellitus. Cytokine. 2024 Sep;181:156692. doi: 10.1016/j.cyto.2024.156692. (Impact Factor: 3.7). (Corresponding author).
3. Madhubala D, Mahato R, Khan MR, Bala A, Mukherjee AK. Neurotrophin peptidomimetics for the treatment of neurodegenerative diseases. Drug Discov Today. 2024 Sep 2:104156. doi: 10.1016/j.drudis.2024.104156. (Impact Factor: 6.5). (Co- author).
4. Piyali Devroy, Suraj Kumar Chatterjee, Rahul Singh, Satyabrata Mohapatra, Sagnik Haldar, Ashis K. Mukherjee, Asis Bala, Candy leaf - Stevia rebaudiana (Bertoni) Bertoni attenuated LPS-induced protein kinase C phosphorylation in mouse macrophages cells: Target search by network pharmacology and validation using ex vivo and in vivo assays,Food Bioscience, Volume 61, 2024,104809,https://doi.org/10.1016/j.fbio.2024.104809. (Impact Factor: 4.8). (Corresponding author).
5. Kumkar PS, Chakraborty R, Upadhyay AM, Das JM, Bala A. Preliminary study on cytotoxicity of selegiline on different cancer cell lines: exploration of the induction of ROS-independent apoptosis in breast cancer cells. Med Oncol. 2024 Jul 20;41(8):204. doi: 10.1007/s12032-024-02451-0. (Impact Factor: 2.8). (Corresponding author).
6. Mooko T, Bisiwe FB, Mondleki E, Morobadi MD, Chikobvu P, Nyaga MM, Bala A, Goedhals D, Mofokeng TRP, Kemp G, Ndlovu KCZ. Steady-state pharmacokinetics of lamivudine in end-stage kidney failure persons with detectable and undetectable HIV-1 RNA in peritoneal dialysis effluent. Eur J Med Res. 2024 Jul 18;29(1):374. doi: 10.1186/s40001-024-01972-8. (Impact Factor: 2.8). (Co- author).
7. Bala A. Regulatory role of peroxynitrite in advanced glycation end products mediated diabetic cardiovascular complications. World J Diabetes 2024; 15(3): 572-574 [DOI: 10.4239/wjd.v15.i3.572] (Impact Factor: 4.2). (Sole Author).
8. Gayen S, Jana S, Das Gupta B, Ghosh A, Kar A, Bala A, Mukherjee PK, Haldar PK. Exploration of anti-diabetic activity and metabolite profiling of Bruguiera cylindrica (l.) Bl.-in vivo anti-diabetic activity, exploration of molecular mechanism, and network pharmacological analysis. J Pharm Pharmacol. 2024 Mar 28:rgae030. doi: 10.1093/jpp/rgae030. (Impact Factor: 3.3). (Co- Author).
9. Abdullah S.,  Chakraborty R.,  Kumkar P.S., Debnath B.,  Bala A. Molecular Pathogenesis, Organ Metastasis, and Targeted Therapy for Non-Small Cell Lung Cancer (NSCLC).Journal of Environmental Pathology, Toxicology and Oncology. 2024. DOI: 10.1615/JEnvironPatholToxicolOncol.2024051317. (Impact Factor: 2.4). (Corresponding Author).
10. Pramanik S, Bala A, Pradhan A. Zebrafish in understanding molecular pathophysiology, disease modeling, and developing effective treatments for Rett syndrome. J Gene Med. 2024 Feb;26(2):e3677. doi: 10.1002/jgm.3677. (Impact Factor: 3.5). (Co- Author).
11. Patra A*, Bala A*, Khan MR, Mukherjee AK. A Correlation Study to Comprehend the SAR-COV-2 Viral Load, Antiviral Antibody Titer, and Severity of COVID-19 Symptoms Post-infection Amongst the Vaccinated Population in Kamrup District of Assam, Northeast India. Endocr Metab Immune Disord Drug Targets. 2024 Jan 12. doi: 10.2174/0118715303281124231213110004. (Impact Factor: 1.9). (Joint First Author).

2022- 2023 (IASST)

1. Changkakoti L, Das JM, Borah R, Rajabalaya R, David SR, Balaraman AK, Pramanik S, Haldar PK, Bala A. Protein Kinase C (PKC)-mediated TGF-β Regulation in Diabetic Neuropathy: Emphasis on Neuro-inflammation and Allodynia. Endocr Metab Immune Disord Drug Targets. 2023 Nov 6. doi: 10.2174/0118715303262824231024104849. (Impact Factor: 1.9). (Corresponding author).
2. Bala A. Importance of protein kinase C (PKC) in phosphorylation of AMP-activated protein kinase (AMPK) in endocrine control. Endocrine. 2023 Oct 21. doi: 10.1007/s12020-023-03576-4. (Impact Factor: 3.7). (Sole author).
3. Sur D, Mondal C, Balaraman AK, Haldar PK, Maji HS, Bala A. Attenuation of COX-2 enzyme by modulating H₂O₂-mediated NF-κB signaling pathway by monoamine oxidase inhibitor (MAOI): a further study on the reprofiling of MAOI in acute inflammation. Inflammopharmacology. 2023 Feb 24. doi: 10.1007/s10787-023-01165-5. (Impact Factor: 5.8). (Corresponding author).
4. Jana S, Gayen S, Dasgupta B, Singha S, Mondal J, Kar A, Nepal A, Ghosh S, Rajabalaya R, David SR, Balaraman AK, Bala A, Mukherjee PK, Haldar PK. Investigation on anti-diabetic efficacy of a Cucurbitaceae food plant from the North-East region of India: Exploring the molecular mechanism through modulation of oxidative stress and glycosylated hemoglobin (HbA1c). Endocr Metab Immune Disord Drug Targets. 2023 Sep 7. doi: 10.2174/1871530323666230907115818 (Impact Factor: 1.9). (Co author).
5. Bala Asis.  A need for clinical trial: re-purposing the MAO-I for rheumatoid arthritis (RA). DOI : 10.1007/s10787-023-01310-0. 2023.  (Impact Factor: 5.8). (Sole author).
6. Maitra S, Bhattacharya D, Paul S, Ghosh Chowdhury P, Mandal D, Haldar PK, Kumar Balaraman A, Bala A. Programmed Cell Death Protein 1 (PD-1) in relation to PANoptosis: Immune Pharmacological Targets for Management of Breast Adenocarcinoma. Endocr Metab Immune Disord Drug Targets. 2023 Feb 13. doi: 10.2174/1871530323666230213121803. (Impact Factor: 2.387). (Corresponding author).
7. Sarkar P, Banu S, Bhattacharya S,Bala A, Sur D. Pathophysiology Associated with Diabetes-induced Tauopathy and Development of Alzheimer's Disease. Curr Diabetes Rev. 2023;19(5): e130522204763. doi: 10.2174/1573399818666220513142030. (Impact Factor: 3.3).(Co-Author)
8. Patra S, Bala A, Sharma N, Haldar PK. Developmental Toxicity Assessment of Drymaria Cordata(Linn.) Willd using Zebrafish Embryo. Curr Drug Saf. 2023;18(2):214-223. doi: 10.2174/1574886317666220514153858. (Impact Factor: 1.5).(Co-Author)
9. Sur D, Dutta A, Mondal C, Banerjee A, Haldar PK, Maji HS, Bala A. Repurposing monoamine oxidase inhibitors (MAOI) for the treatment of rheumatoid arthritis possibly through modulating reactive oxidative stress mediated inflammatory cytokines.. Inflammopharmacology. 2022Apr;30(2):453-463. (Impact Factor: 5.098). (Corresponding author).

Solely Edited Book:

Diabetes and Breast Cancer: An Analysis of Signaling Pathways - 2024

Bentham Book Publication : https://www.eurekaselect.com/ebook_volume/3707

Book Chapter:

• Talukdar, P., Chakraborty, R., Goswami, A., Deori, C. and Bala, A. (2026). Green Toxicology and Safety Assessment of Biogenic Nanoparticles. In Biogenic Synthesis of Nanoparticles and Sustainable Nanotherapeutics, M.K. Das (Ed.).Wiley.  https://doi.org/10.1002/9781394311330.ch14.
• Jana, S. Bala A., et al. (2024). Production of Biopharmaceuticals on Genetically Modified Organisms. In: Bose, S., Shukla, A.C., Baig, M.R., Banerjee, S. (eds) Concepts in Pharmaceutical Biotechnology and Drug Development . Interdisciplinary Biotechnological Advances. Springer, Singapore. https://doi.org/10.1007/978-981-97-1148-2_6
• Susmita Patra, Ratul Chakraborty, Motlalepula G. Matsabisa, Asis Bala ;Interplay between Diabetes and Breast Cancer: A Brief Report, Diabetes and Breast Cancer: An Analysis of Signaling Pathways (2024) 1: 1. https://doi.org/10.2174/9789815256024124010005
• Ratul Chakraborty, Debanjana Das, Ayan Goswami, Rajan Rajabalaya, Sheba R. David, Ashok Kumar Balaraman, S. Hemalatha, Asis Bala ;Insulin and Hypoxia in Breast Cancer Cell Invasion and Migration, Diabetes and Breast Cancer: An Analysis of Signaling Pathways (2024) 1: 48. https://doi.org/10.2174/9789815256024124010007
• Sandipan Jana, Suraj Kumar Chatterjee, Asis Bala*, Pallab Kanti Haldar*;Genetic Similarity between Type 2 Diabetes and Breast Cancer: A Brief Report, Diabetes and Breast Cancer: An Analysis of Signaling Pathways (2024) 1: 66. https://doi.org/10.2174/9789815256024124010008
• Piyali Devroy, Ratul Chakraborty, Sanjib Bhattacharya, Asis Bala ;Recent Advances in Medicinal Plant Research in the Concomitant Management of Diabetes and Breast Cancer, Diabetes and Breast Cancer: An Analysis of Signaling Pathways (2024) 1: 180. https://doi.org/10.2174/9789815256024124010013
• Jitu Mani Das, Asis Bala, Jnanendra Upadhyay, Rajiv Borah, “Role of nanotechnology in crop management” In Nanotechnology for Abiotic Stress Tolerance and Management in Crop Plants, Elsevier, 2023. ISBN: 9780443185007. https://shop.elsevier.com/books/nanotechnology-for-abiotic-stress-tolerance-and-management-in-crop-plants/pudake/978-0-443-18500-7
• Asis Bala, Motlalepula Gilbert Matsabisa, Pallab Kanti Haldar, Subir Biswas And Ashis Kumar Mukherjee. Superoxide (O2-): A Biological Prodigy for Developing and Curing Disease. The Role of Reactive Oxygen Species in Health and Disease. NOVA Science Publications, 2024. Edited by Kuladip Jana. https://novapublishers.com/shop/the-role-of-reactive-oxygen-species-in-health-and-disease/

2021- 2022 & Beyond

1. Matsabisa MG, Bala A, Tripathy S, Digashu MM, Rautenbach F, Dassarma B, Erhabor JO, Braga FC, Mukherjee PK, Tang M, Kang Y. Study on South African Indigenous Teas-Antioxidant Potential, Nutritional Content, and Hypoxia-Induced Cyclooxygenase Inhibition on U87 MG Cell Line. Molecules. 2022 May 30;27(11):3505. doi: 10.3390/molecules27113505. (Impact Factor: 4.2). (Co- author).
2. Bala A, Sengupta A, Matsabisa MG, Chabalala HP COVID-19: Pathophysiology; Mechanism of Transmission and Possible Molecular Drug Target for Management.. Curr Mol Pharmacol. 2020 Aug 30. doi: 10.2174/1874467213999200831104324. (Impact Factor = 3.855). (First and corresponding author).
3. Mooko T, Bala A, Tripathy S, Kumar CS, Mahadevappa CP, Chaudhary SK, Matsabisa MG Cannabis Sativa L. Flower and Bud Extracts inhibited In vitro Cholinesterases and b-Secretase Enzymes Activities: Possible Mechanisms of Cannabis use in Alzheimer Disease.. Endocr Metab Immune Disord Drug Targets. 2021 Feb 22. doi: 10.2174/1871530321666210222124349. (Impact Factor = 2.387). (Co- author).
4. Bala A, Panditharadyula Role of Nuclear Factor Erythroid 2-Related Factor 2 (NRF-2) Mediated Antioxidant Response on the Synergistic Antitumor Effect of L-Arginine and 5-Fluro Uracil (5FU) in Breast Adenocarcinoma. Curr Pharm Des. 2019;25(14):1643-1652. (Impact Factor = 3.31). (First and corresponding author).
5. Bala Asis, Matsabisa Possible importance of Cannabis sativa L. in regulation of insulin and IL-6R/MAO-A in cancer cell progression and migration of breast cancer patients with diabetes. SA Journal of Science 2018;114(7/8), http://dx.doi. org/10.17159/sajs.2018/a0279. (Impact Factor: 2.134). (First author).
6. Bala Asis, Mondal , Haldar PK., Khandelwal B. Oxidative stress in inflammatory cells of patient with Rheumatoid Arthritis: Clinical Efficacy of Dietary Antioxidants. Inflammopharmacol. 2017. 25(6):595-607. (Impact Factor: 5.093). (First and corresponding author).
7. Bala Asis, Rademan Sunelle, Ndiyhuwo Khorommbi Kevin, Maharaj Ninesh, Matsabisa Motlalepula UPLC-MS analysis of Cannabis sativa L usingtetrahydrocannabinol (THC), Cannabidiol (CBD) and tetrahydrocannabinolic acid (THCA) as marker compounds: Inhibition of breast cancer cell survival and progression. Natural Product Communications. 2019. https://doi.org/10.1177/1934578X19872907 (Impact Factor: 1.496). (First author).
8. Bala Asis. Mukherjee PK. Braga FC. Matsabisa MG. Comparative inhibition of MCF-7 breast cancer cells growth, invasion and angiogenesis by Cannabis sativa sourced from sixteen different geographic locations. SA J Botany, Volume 119, November 2018, Pages 154-162. (Impact Factor: 3.111). (First author).
9. Bala Asis. Chetia P, Dolai N, Khandelwal B, Haldar Cat’s whiskers flavonoid attenuated oxidative DNA damage in macrophages cells: Its Importance in patients with Rheumatoid Arthritis. Inflammopharmacol. 2014; 22(1):55-61. (Impact Factor: 5.093). (First and corresponding author).
10. Kundu S., Bala Asis, Ghosh P., Mitra A., Sarkar A., Bauri , Ghosh A., Chattopadhyay S., Chatterjee M., Attenuation of oxidative stress by Allylpyrocatechol in synovial cellular infi ltrate of patients with Rheumatoid Arthritis. Free Radical Research, 2011. 45(5): 518-526. (Impact Factor: 4.354). (Co- author).
11. Bala Asis, Haldar PK., Kar B., and Naskar S., and Mazumder UK., Carbon tetrachloride: A hepatotoxin causes oxidative stress in murine peritoneal macrophage and peripheral blood lymphocyte Immunopharmacol Immunotoxicol. 2012. 34:135–142. (Impact Factor: 3.712). (First and corresponding author).
12. Chakraborty M, Bala Asis, Bhattacharya S, Haldar Pharmacog. Hypoglycemic effect of ethyl acetate fraction of methanol extract from Campylandra aurantiaca rhizome on high fat diet and low dose streptozotocin- induced diabetic rats. Pharmacog. Mag. 2018; 14(59): 539-545. (Impact Factor: 0.948). (Co- author).
13. N Dolai, I Karmakar, RB Suresh Kumar, Bala Asis, UK Mazumder, Antitumor potential of Castanopsis indica (Roxb. ex Lindl.) A. DC. Leaf extract against Ehrlich's ascites carcinoma cell. Indian Journal of Experimental Biology. 2012. 50 (5), (Impact Factor: 0.944). (Co- author).
14. Dolai N, Karmakar I, Suresh Kumar RB, Kar B, Bala Asis, Haldar PK. Evaluation of antitumor activity and in vivo antioxidant status of Anthocephalus cadamba on Ehrlich ascites carcinoma treated mice. J Ethnopharmacol. 2012; 1;142(3):865-70. (Impact Factor: 195). (Co- author).
15. Bala Asis, Kar B., Karmakar I., Kumar RBS., Haldar PK., Antioxidant activity of Cat’s whiskers flavonoid on some reactive oxygen and nitrogen species generating inflammatory cells is mediated by scavenging of free radical, Chin J Natural Medicine. 2012. 10(5): 321-327. (Impact Factor: 3.00). (First and corresponding author).
16. Naskar S, Mazumder UK, Pramanik G, Gupta M, Kumar RB, Bala Asis, Islam. Evaluation of antihyperglycemic activity of Cocos nucifera on streptozotocin induced type 2 diabetic rats. J Ethnopharmacol. 2011; 8;138(3):769-73. (Impact Factor: 5.195). (Co- author).
17. Bala Asis, Kar , Haldar PK., Mazumder UK., Bera S., Evaluation of anticancer activity of Cleome gynandra on Ehrlichs' Ascites Carcinoma treated mice. Journal of Ethnopharmacol. 2010. 129: 131-134. 2011. (Impact Factor: 5.195). (First and corresponding author).
18. Haldar PK., Bhattcharya S., Bala Asis, Kar B., Mazumder UK.,Dewanjee S. Chemopreventive role of Indigofera aspalathoides against 20- methylcholanthrene-induced carcinogenesis in Toxicological & Environmental Chemistry. 2010. 92: (9); 1749-1763. (Impact Factor: 1.565).(Co-author).
19. PK Haldar, B Kar, Bala Asis, S Bhattacharya, UK Antitumor activity of Sansevieria roxburghiana rhizome against Ehrlich ascites carcinoma in mice. Pharmaceutical Biology. 2010. 48 (12), 1337-1343. (Impact Factor: 3.889). (Co- author).
20. Bala, A., Haldar, P.K., Kar, B., (...), Gupta, M., Mazumder, U.K. Antioxidant activity of the fractions of Cleome gynandra promotes antitumor activity in Ehrlich Ascites Carcinoma. Asian Journal of Chemistry 23(11), 5055-5060. (First and corresponding author).
21. Das, S., Bala, A., Bhowmik, M., Ghosh, L.K. Attenuation of reactive nitrogen species by different flavonoids enriched fractions of Schima Wallichii. Asian Pacific Journal of Tropical Asian Pacific Journal of Tropical Biomedicine. 2012. 2(2),S632-S636. (Impact Factor: 1.514).  (Co- author).
22. Kar, B., Kumar, R.B.S., Karmakar, I., Dolai N., Bala A., Mazumder, U.K., Hadar, P.K. Antioxidant and in vitro anti-inflammatory activities of Mimusops elengi leaves. Asian Pacific Journal of Tropical Biomedicine. 2012. 2(2), S976- (Impact Factor: 1.514). (Co- author).
23. Dolai, N., Karmakar, I., Kumar, R.B.S., (...), Bala, A., Haldar, P.K. Free radical scavenging activity of Castanopsis indica in mediating hepatoprotective activity of carbon tetrachloride intoxicated Asian Pacific Journal of Tropical Biomedicine 2(1), pp. S243-S251. (Impact Factor: 1.514). (Co- author).

 Book Chapter Publication    

• Isolation and HPLC characterization of the flavonoid fractions from Cleome gynandra and comparative antioxidant Bala Asis, Karmakar I., Haldar PK., In: Recent Progress in Medicinal Plants- Ethnomedicine and Theraputic validation, Edited by Dr. J.N. Govil, Studium Press USA Vol. No. 32, Ch. 10, Page 225-240. 2012. (First and corresponding author).
• Debjeet Sur, Pallab Kanti Haldar, Himangshu Sekhar Maji, Ashok Kumar Balaraman, Lopamudra Roy, Asis Bala ;Role of GSK-3 in the Regulation of Insulin Release and Glucose Metabolism, Free Radical Biology of Endocrine, Metabolic & Immune Disorders (2022) 1: 42. https://doi.org/10.2174/9789815049220122010006.
• Debanjana Das, Sumit Kumar, Asis Bala, Chaitali Mondal ;Regulatory Role of Immune Cell-mediated Antibodies in Rheumatoid Arthritis, Free Radical Biology of Endocrine, Metabolic & Immune Disorders (2022) 1: 113. https://doi.org/10.2174/9789815049220122010009.

Book Publication (Sole Editor)

Free Radical Biology of Endocrine, Metabolic and Immune Disorders; Editor Asis Bala; In Press Bentham Publishers 2022. https://benthambooks.com/book/9789815049220

Patent (Published & FILED)- 

• Filed a Patent to Intellectual Property India “A Method for Isolation of Neuroprotective Bioactive Peptides from Fermented Fish (Telesh Shidal) and Compositions Thereof” Application No. 202631060953 filed on 13.05.2026. (As co-Inventor: Dr. Asis Bala)
• Filed a Patent to Intellectual Property India "Zebra Fish Egg Collection Device"- (Application Number: 2016310632499) The Indian Patent Office Journal 13/2018 Dated 30/03/2018 (Filed & Published). (Inventor: Dr. Asis Bala)
• Filed a Patent to Intellectual Property India -Govt. of India "Hydrophobically modified water soluble derivative of chitosan as potential hemostatic agent". Filed: Docket No 8116 Intellectual Property India 2020. (As Co-Inventor)

PHARMACOLOGY AND DRUG DISCOVERY RESEARCH LAB. (PDDRL):

Supervisor: Dr. Asis Bala, Associate Professor- I, Division of Life Science, IASST

Post Doctoral Fellow:

• Dr. Dorothy Das [I-PDF]-Completed: 2024-2026

JRF /PhD Research Fellow:

• Ms. Abhipsha Saikia- [IJRF-PhD Enrolled in AcSIR]
• Ms. Punam Talukdar - [IJRF-PhD Enrolled in AcSIR]
• Ms. Piyali Devroy -[IJRF-PhD Enrolled in AcSIR]
• Mr. Ratul Chakraborty -[CSIR UGC NET JRF -PhD Enrolled in AcSIR]
• Mr. Jyotirmoy Das, [Project Associate, DBT (QAQC) Project]
• Ms. Upashana Patgiri, [Project Associate, DBT (QAQC) Project]
• Ms. Banita Nath, [Project Associate, DBT (QAQC) Project]
• Mr. Bishal Saha, [Project Associate, DBT (QAQC) Project]
• Ms. Drishti Saha, [Project Assistant, DBT (QAQC) Project]
• ------------------------------------------------------------------------------
• Ms. Liza Changkakoti -[Field Worker, & IJRF] Completed: 2023-2025
• Mr. Jitu Mani Das -[JRF- DBT Project]- Completed 2024

Project Dissertation (M.Pharm/M.Tech./M.Sc.) & Summer Internship:

• Ms. Debashruti Gogoi- [Gauhati University] -Ongoing [2026]
• Ms. Niharika Mazumdar- [Gauhati University] -Ongoing [2026]
• Mr. Dhruba Jyoti Borah - [NIPS] -Ongoing [2025-26]
• Mr. Shreyansh Saha - [NIPS] -Ongoing [2025-26]
• Mr. Safiqul Haque - [NIPS] -Ongoing [2025-26]
• Ms. Khyati Mishra- [NIPS] -Ongoing [2025-26]
• Mr. Sumeet Kumar Das - [NIPS] -Completed [2026]
• Ms. Bidisha Deka- [Gauhati University] -Completed [2026]
• Mr. Priyanshu Rawat [G.G.S. Indraprastha University]- Completed [2025]
• Ms. Akhita Konwar [Digboi College]- Completed [2025]
• Ms. Bishmita Gogoi [Digboi College]- Completed [2025]
• Ms. Diksha Chakraborty [KIIT] -Completed [2025]
• Ms. Upashana Pathgiri - [NIPS] -Completed [2024-25]
• Ms. Nishijyoti Choudhury - [NIPS] -Completed [2024-25]
• Ms. Dhritismita Das - [Guwahati University] -Completed [2025]
• Ms. Sparshita Dey - [GNIPST-MAKAUT WB] -Completed [2024]
• Ms. Kiran Biswas - [Dibrugarh University] -Completed [2024]
• Mr. Aravind Sai Bharathy K. –[Anna University]- Completed [2024]
• MD. Asif J –[Anna University]- Completed [2024]
• Mr. Suraj Kumar Chatterjee –[Techno India University]- Completed [2023]
• Ms. Pratiksha S. Kumkar –[NIPER-Guwahati]- Completed [2023-24]
• Mr. Abhishek M. Upadhaya –[Parul University]- Completed [2023]
• Mr. Surya S. –[Anna University]- Completed [2023]

Interested Students having a basic Master's Degree (MSc, M.Pharm.,M.S., M.Tech.) in any branches of Life Sciences (Pharmacy, Biotechnology, Zoology, Biochemistry etc) may contact me and send CV and cover letter via email - asisbala[at]iasst[dot]gov[dot]in

Students with valid UGC CSIR, DBT or ICMR JRF may apply for IASST rolling Advertisement for PhD admission 2025/check IASST website for more details